Schoenebaum Likes United Therapeutics, Biogen Idec

April 2 (Bloomberg) -- Mark Schoenebaum, an analyst with ISI Group, talks about his investment strategy and stock picks for shares of biotechnology companies. He speaks with Adam Johnson and Trish Regan on Bloomberg Television's "Street Smart." (Source: Bloomberg)